Related Experiment Videos

Primitive neuroectodermal tumor of the midbrain in a murine model of retinoblastoma

D M Marcus1, J L Carpenter, J M O'Brien

  • 1David G. Cogan Eye Pathology Laboratory, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston 02114.

Insights

Researchers created the first heritable retinoblastoma model using transgenic mice. This model accurately mimics human trilateral retinoblastoma, including central nervous system tumors.

Area of Science:

  • Oncology
  • Genetics
  • Neuroscience

Background:

  • Retinoblastoma is a pediatric eye cancer.
  • Trilateral retinoblastoma involves both eyes and the brain.
  • A heritable mouse model for retinoblastoma is needed.

Purpose of the Study:

  • To establish the first heritable mouse model of retinoblastoma.
  • To characterize the resulting ocular and central nervous system tumors.
  • To compare the murine model to human trilateral retinoblastoma.

Main Methods:

  • Retina-specific expression of simian virus 40 T-antigen (SV40 T-ag) in transgenic mice.
  • Histopathological and immunohistochemical analysis of tumors.
  • Ultrastructural examination of tumor cells.

Main Results:

  • 100% of transgene-bearing mice developed bilateral, multifocal ocular tumors.
  • 27% of mice developed central nervous system neoplasms, resembling human trilateral retinoblastoma.
  • Murine brain tumors were primitive neuroectodermal tumors (PNETs) originating from subependymal cells, distinct from the pineal gland.

Conclusions:

  • The transgenic mouse model successfully replicates heritable retinoblastoma and aspects of trilateral retinoblastoma.
  • This model provides a valuable tool for studying retinoblastoma pathogenesis and treatment.
  • The murine PNETs offer insights into undifferentiated suprasellar/parasellar tumors in human trilateral retinoblastoma.

Related Concept Videos